Real-world evidence on the additional cancer risk reduction of ezetimibe: a 10-year nationwide retrospective cohort study emulating a target trial.

ABSTRACT:

SUBMITTER: Lim Y 

PROVIDER: S-EPMC12477099 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature